Renal involvement as a manifestation of rapidly progressive systemic sclerosis: Two clinical cases
PDF (Español)

Keywords

Acute kidney injury
Systemic scleroderma
Diffuse scleroderma
Kidney diseases

How to Cite

1.
Medina LD, Vargas-Ángel DC, Contreras-Villamizar K, Rodríguez PV, Amado S, Saa D, Mena-Arévalo AN, Smith S. Renal involvement as a manifestation of rapidly progressive systemic sclerosis: Two clinical cases . Rev. Colomb. Nefrol. [Internet]. 2024 May 24 [cited 2024 Jul. 25];11(1). Available from: https://revistanefrologia.org/index.php/rcn/article/view/749

Abstract

Introduction: Renal involvement due to systemic sclerosis (SS) occurs in 5-15% of patients with diffuse skin involvement, characterized by severe deterioration of renal function, generated by vasculopathy, inflammation and fibrosis.

Purpose: Provide relevant information to improve early recognition of scleroderma renal crisis through the analysis of 2 clinical cases.

Case presentation: Two clinical cases are presented that share characteristics of SS with rapidly progressive skin involvement and kidney disease compatible with scleroderma renal crisis (SRC), manifested as hypertensive crisis and acute kidney injury (AKI), with hemodialysis requirement. Given the suspected diagnosis of SSc, treatment with enalapril was started immediately, achieving control of blood pressure and improvement of intravascular hemolysis. Given the rapid progression of the skin involvement, cyclophosphamide was indicated, presenting improvement in sclerosis in one of the two cases.

Discussion and conclusion: Due to its low frequency and aggressive behavior, SRC continues to be a diagnostic and therapeutic challenge, where prompt treatment represents the difference between achieving clinical results between achieving clinical results, which is why it should be part of the diagnostic approach in patients with AKI and thrombotic microangiopathy, mainly in those who suffer from hypertensive crisis.

https://doi.org/10.22265/acnef.11.1.749
PDF (Español)

References

Yamashita H, Kamei R, Kaneko H. Classifications of scleroderma renal crisis and reconsideration of its pathophysiology. Rheumatology. 2019;58(12):2099-106. https://doi.org/10.1093/rheumatology/kez435

Medina YF y Medina Torres D. Alteraciones renales en la esclerodermia. Rev Colomb Reumatol. 2020;27(S1):55-61. https://doi.org/10.1016/j.rcreu.2020.03.005

Steen VD, Syzd A, Johnson JP, Greenberg A, Medsger TA. Kidney disease other than renal crisis in patients with diffuse scleroderma. J Rheumatol. 2005;32(4):649-55.

Penn H, Howie AJ, Kingdon EJ, Bunn CC, Stratton RJ, Black CM, et al. Scleroderma renal crisis: patient characteristics and long-term outcomes. QJM. 2007;100(8):485-94. https://doi.org/10.1093/qjmed/hcm052

Traub YM, Shapiro AP, Rodnan GP, Medsger TA, McDonald RH, Steen VD, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25-year experience with 68 cases. Medicine. 1983;62(6):335-52. https://doi.org/10.1097/00005792-198311000-00001

Nagaraja V. Management of scleroderma renal crisis. Curr Opin Rheumatol. 2019;31(3):223-30. https://doi.org/10.1097/BOR.0000000000000604

Chabtini L, Mounayar M, Azzi J, Bijol V, Bastacky S, Rennke HG, et al. Scleroderma renal crisis. En: Radstake T, editor. Systemic Sclerosis - An Update on the Aberrant Immune System and Clinical Features. Reino Unido: InTech; 2012. https://doi.org/10.5772/27925

Zubiría MA, Florez Suarez J, Méndez-Patarroyo P, Quintana Ge. Tratamiento farmacológico de la crisis renal en esclerosis sistémica: una revisión sistemática de la literatura. Rev Colomb Reumatol. 2020;27(S1):111-25. https://doi.org/10.1016/j.rcreu.2019.12.006

Zanatta E, Polito P, Favaro M, Larosa M, Marson P, Cozzi F, et al. Therapy of scleroderma renal crisis: state of the art. Autoimmun Rev. 2018;17(9):882-9. https://doi.org/10.1016/j.autrev.2018.03.012

Teixeira L, Mouthon L, Mahr A, Berezné A, Agard C, Mehrenberger M, et al. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients. Ann Rheum Dis. 2008;67(1):110-6. https://doi.org/10.1136/ard.2006.066985

Hudson M, Ghossein C, Varga J. Scleroderma renal crisis. En: Matucci-Cerinic M, Denton CP, editors. Practical Management of Systemic Sclerosis in Clinical Practice. Suiza: Springer Nature; 2021. https://doi.org/10.1007/978-3-030-53736-4_2.

Clements PJ, Lachenbruch PA, Furst DE, Maxwell M, Danovitch G, Paulus HE. Abnormalities of renal physiology in systemic sclerosis. Arthritis Rheum. 1994;37(1):67-74. https://doi.org/10.1002/art.1780370110

Denton CP, Lapadula G, Mouthon L, Müller-Ladner U. Renal complications and scleroderma renal crisis. Rheumatology. 2009;48(supl. 3):iii32-5. https://doi.org/10.1093/rheumatology/ken483

Bose N, Chiesa-Vottero A, Chatterjee S. Scleroderma renal crisis. Semin Arthritis Rheum. 2015;44(6):687-94. https://doi.org/10.1016/j.semarthrit.2014.12.001

Mouthon L, Bussone G, Berezné A, Noël LH, Guillevin L. Scleroderma renal crisis. J Rheumatol. 2014;41(6):1040-8. https://doi.org/10.3899/jrheum.131210

Woodworth TG, Suliman YA, Li W, Furst DE, Clements P. Scleroderma renal crisis and renal involvement in systemic sclerosis. Nat Rev Nephrol. 2016;12(11):678-91. https://doi.org/10.1038/nrneph.2016.124

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Dimensions


PlumX


Downloads

Download data is not yet available.